Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
DOI:
10.1016/j.jddst.2024.106007
Publication Date:
2024-08-05T20:15:10Z
AUTHORS (4)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (365)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....